FOLFIRI-cetuximab regimen

View Patient Information

A chemoimmunotherapy regimen consisting of leucovorin (folinic acid), 5-fluorouracil, and irinotecan plus cetuximab used for the treatment of metastatic colorectal cancer that is positive for the expression of the epidermal growth factor receptor (EGFR) and the wild-type form of KRAS.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	FOLFIRI-Erbitux regimen leucovorin-fluorouracil-irinotecan-cetuximab regimen

FOLFIRI-cetuximab regimen

Search NCI's Drug Dictionary